MCEDC Interview: Greg Merril, CEO of Adaptive Phage Therapeutics

Adaptive Phage Therapeutics’ CEO, Greg Merril, was featured this week in MCEDC’s Built For Bio Video Series. David Petr, CEO of MCEDC, discovers how Greg’s clinical-stage company in Montgomery County, MD is using bacteria phage to combat the worldwide crisis in multi-drug resistant bacterial infections, one of the biggest threats to humankind.

Originally posted:

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.